title: Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection.
authors.forename: Janaki
authors.initials: J
authors.lastname: Amin
authors.forename: Mark A
authors.initials: MA
authors.lastname: Boyd
authors.forename: Nagalingeswaran
authors.initials: N
authors.lastname: Kumarasamy
authors.forename: Cecilia L
authors.initials: CL
authors.lastname: Moore
authors.forename: Marcello H
authors.initials: MH
authors.lastname: Losso
authors.forename: Chidi A
authors.initials: CA
authors.lastname: Nwizu
authors.forename: Lerato
authors.initials: L
authors.lastname: Mohapi
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Kerr
authors.forename: Annette H
authors.initials: AH
authors.lastname: Sohn
authors.forename: Hedy
authors.initials: H
authors.lastname: Teppler
authors.forename: Boris
authors.initials: B
authors.lastname: Renjifo
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Molina
authors.forename: Sean
authors.initials: S
authors.lastname: Emery
authors.forename: David A
authors.initials: DA
authors.lastname: Cooper